跳至主要内容
临床试验/JPRN-UMIN000023822
JPRN-UMIN000023822已完成未知

Prospective study of evaluation to the predictive biomarker of Nivolumab by tumor tissue specimen and neighboring bronchoaveolar lavage fluid (BALF) and Blood - Evaluation to the predictive biomarker of Nivolumab by Tumor tissue, BALF, and Blood

Respiratory Medicine, Allergy and Rheumatic Diseases Osaka University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2016年8月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)With interstitial pneumonia or pulmonary fibrosis on a chest X-ray (2)Clinically significant drug allergy (3)Presencee of other active malignancy (4)With pericardial effusion, pleural effusion and ascites in need of treatment of drainage (5)Positive serum HBs antigen (6)With severe infection, cardiac diseases, diabates, hypertention, other severe complication (7)Patients received palliative radiotherapy for brain metastases and bone metastases, except for the primary lesion within 2weeks. (8)Pregnancy or lactating patients (9)The case that be judged as the inappropriate object of the this examination

研究者

发起方
Respiratory Medicine, Allergy and Rheumatic Diseases Osaka University Graduate School of Medicine

相似试验

Prospective study of evaluation to the predictive... | 临床试验